Lack of association between macrophage migration inhibitory factor gene promoter (-173 G/C) polymorphism and childhood Henoch-Schönlein purpura in Turkish patients

Cytokine

Volumn 62, Issue 1, 2013, Pages 160-164

  Nalbantoglu, Sinem ^a   Tabel, Yilmaz ^b   Mir, Sevgi ^a   Berdeli, Afig ^a  

^a EGE UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Genotype phenotype correlation; Henoch Sch nlein purpura (HSP); Macrophage migration inhibitory factor (MIF); Organ involvements; Single nucleotide polymorphism (SNP)

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADOLESCENT; ANAPHYLACTOID PURPURA; ARTHROPATHY; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERTENSION; KIDNEY DISEASE; MACROPHAGE MIGRATION INHIBITION FACTOR GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SCHOOL CHILD; TURKEY (REPUBLIC);

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PURPURA, SCHOENLEIN-HENOCH; TURKEY;

EID: 84875804718     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.02.024     Document Type: Article

References (51)

1. D'Arsigny C. Small vessel vasculitis and the pulmonary-renal syndrome. Ont Thorac Rev 2006, 18(3):4-7. 1.
2. Gedalia A. Henoch-Schönlein purpura. Curr Rheumatol Rep 2004, 6:195-202.
3. Tizard E.J., Hamilton-Ayres M.J. Henoch-Schönlein purpura. Arch Dis Child Educ Pract Ed 2008, 93:1-8.
4. Ballinger S. Henoch-Schönlein purpura. Curr Opin Rheumatol 2008, 15:591-594.
5. Leung D.Y. Immunologic aspects of Kawasaki syndrome. J Rheumatol Suppl 1990, 24:15-18.
6. Cohen TJ, Kallenberg CG. In: The TH, De Kallenberg CGM, Leij L, editors. Vasculitis, klinische immunologie. Houten/Antwerpen: Bohn Stafleu Van Loghum; 1991. p. 216-33.
7. Shi{dotless}mi{dotless}zu T., Abe R., Ni{dotless}shi{dotless}hi{dotless}ra J. Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice. Eur J Immunol 2003, 33:1478-1487.
8. Leech M., Metz C., Hall P., Hutchinson P., Gianis K., Smith M., et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheu 1999, 42:1601-1608.
9. Bloom B.R., Bennett B. Mechanism of a reaction in vitro associated with delayed type hypersensitivity. Science 1966, 153:80-82.
10. Calandra T., Echtenacher B., Roy D.L., et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000, 6:164-170.
11. Baugh J.A., Chitnis S., Donnelly S.C., Monteiro J., Lin X., Plant B.J., et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002, 3:170-176.
12. Renner P., Roger T., Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 2005, 41(Suppl 7):S513-S519.
13. Donn R., Alourfi Z., De Benedetti F., Meazza C., Zeggini E., Lunt M., et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheu 2002, 46:2402-2409.
14. De Benedetti F., Meazza C., Vivarelli M., Rossi F., Pistorio A., Lamb R., et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheu 2003, 48:1398-1407.
15. Ami{dotless}chai{dotless} B., Grunwald Mh., Halevy S. Allergic vasculitis induced by decapeptyl: confirmation by macrophage migration inhibition factor (MIF) test. Eur J Obstet Gynecol Reprod Biol 1993, 52:217-218.
16. Ohwatari{dotless} R., Fukuda S., Iwabuchi{dotless} K., Inuyama Y., Onoe K., Ni{dotless}shi{dotless}hi{dotless}ra J. Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis. Ann Otol Rhinol Laryngol 2001, 110:1035-1040.
17. Amoli{dotless} M.m., Donn R.p., Thomson W. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 2002, 29:1671-1673.
18. Xia H.h.x., Lam S.k., Huang X.r. Helicobacter pylori infection is associated with increased expression of macrophage migration inhibitory factor by epithelial cells, T cells and macrophages in gastric mucosa. J Infect Dis 2004, 190:293-302.
19. Calandra T., Bucala R. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflamm 1995, 47:39-51.
20. Bozza M., Satoskar A.R., Lin G. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999, 189:341-346.
21. Donnelly S.C., Haslett C., Reid P.T. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997, 3:320-323.
22. Barton A., Lamb R., Symmons D., Silman A., Thomson W., Worthington J., et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 2003, 4:487-491.
23. Wu S.P., Leng L., Feng Z., Liu N., Zhao H., McDonald C., et al. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. Arthritis Rheu 2006, 54:3661-3669.
24. Hizawa N., Yamaguchi E., Takahashi D., Nishihira J., Nishimura M. Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med 2004, 169:1014-1018.
25. Meyer-Siegler K.L., Vera P.L., Iczkowski K.A., Bifulco C., Lee A., Gregersen P.K., et al. Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun 2007, 8:646-652.
26. Donn R.P., Plant D., Jury F., Richards H.L., Worthington J., Ray D.W., et al. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 2004, 123:484-487.
27. Mizue Y., Ghani S., Leng L., McDonald C., Kong P., Baugh J., et al. Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci USA 2005, 102:14410-14415.
28. Foote A., Briganti E.M., Kipen Y., Santos L., Leech M., Morand E.F. Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol 2004, 31(2):268-273.
29. Nielsen H.E. Epidemiology of Schönlein-Henoch purpura. Acta Paediatr Scand 1988, 77:125-131.
30. Amoli M.M., Calviño M.C., Garcia-Porrua C., Llorca J., Ollier W.E., Gonzalez-Gay M.A. Interleukin 1beta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 2004, 31(2):295-298.
31. Amoli M.M., Martin J., Miranda-Filloy J.A., Garcia-Porrua C., Ollier W.E., Gonzalez-Gay M.A. Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura. Clin Exp Rheumatol 2007, 25(1 Suppl 44):S6-S9.
32. Amoli M.M., Martin J., Miranda-Filloy J.A., Garcia-Porrua C., Ollier W.E., Gonzalez-Gay M.A. Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis. Clin Exp Rheumatol 2006, 24(5):576-579.
33. Amoli M.M., Thomson W., Hajeer A.H., Calviño M.C., Garcia-Porrua C., Ollier W.E., et al. Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 2002, 29(11):2367-2370.
34. Amoli M.M., Thomson W., Hajeer A.H. Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 2001, 29:1404-1407.
35. Tahan F., Dursun I., Poyrazoglu H., Gurgoze M., Dusunsel R. The role of chemokines in Henoch Schönlein purpura. Rheumatol Int 2007, 27(10):955-960.
36. Topaloglu R., Sungur A., Baskin E., Besbas N., Saatci U., Bakkaloglu A. Vascular endothelial growth factor in Henoch-Schönlein purpura. J Rheumatol 2001, 28(10):2269-2273.
37. Wu T.H., Wu S.C., Huang T.P., Yu C.L., Tsai C.Y. Increased excretion of tumor necrosis factor alpha and interleukin 1β in urine from patients with IgA nephropathy and schönlein-Henoch purpura. Nephron 1996, 74:79-88.
38. Yang Y.H., Lai H.J., Kao C.K., Lin Y.T., Chiang B.L. The association between transforming growth factor-beta gene promoter C-509T polymorphism and Chinese children with Henoch-Schönlein purpura. Pediatr Nephrol 2004, 19(9):972-975.
39. Yu Y.H., Pan K.L., Li Q., Zhang B.J., Huang Y., Zhang J.J., et al. Roles of serum and urinary interleukins 13Ralpha2 and other cytokines in pediatric Henoch-Schönlein purpura. Zhongguo Dang Dai Er Ke Za Zhi 2009, 11(1):37-40.
40. Soylemezoglu O., Peru H., Gonen S. CTLA-4 +49 A/G genotype and HLA-DRB1 polymorphisms in Turkish patients with Henoch-Schönlein purpura. Pediatr Nephrol 2008, 23:1239-1244.
41. Kim S.D., Park J.M., Kim I.S. Association of IL-1b, IL-1ra, and TNF-a gene polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol 2004, 19:295-299.
42. Gregersen P.K., Bucala R. Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheu 2003, 48:1171-1176.
43. *C allele with childhood nephrotic syndrome. Pediatr Nephrol 2008, 23(5):743-748.
44. Ji{dotless}n Yan-Liang, Wu Jie, Zhou Wei, Yi{dotless}n Lei, Zhou Zheng-Yu, Yang Zheng Study of TNFα, MIF and IL-10 in children with Henoch-Schönlein purpura. J Clin Pediatr 2009, 27(12). 1153-04.
45. Amoli{dotless} M.m., Garci{dotless}a-Porrua C., Olli{dotless}er W.e., Gonzalez-Gay M.a. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis. J Rheumatol 2005, 32:74-76.
46. Berdeli Afig, Özyürek Arif Ruhi, Ülger Zülal, Gürses Dolunay, Levent Ertürk, Salar Koray, et al. Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol Int 2006, 26(8):726-731.
47. Simonini G., Corinaldesi E., Massai C., Falcini F., Fanti F., De Martino M., et al. Macrophage migration inhibitory factor -173 polymorphism and risk of coronary alterations in children with Kawasaki disease. Clin Exp Rheumatol 2009, 27(6):1026-1030.
48. Fei B.Y., Lv H.X., Yang J.M., Ye Z.Y. Association of MIF -173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine 2008, 41(1):44-47.
49. Griga T., Wilkens C., Wirkus N., Epplen J., Schmiegel W., Klein W. A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn's disease and associated with cumulative steroid doses. Hepatogastroenterology 2007, 54(75):784-786.
50. Wu J., Fu S., Ren X., Jin Y., Huang X., Zhang X., et al. Association of MIF promoter polymorphisms with childhood asthma in a northeastern Chinese population. Tissue Antigens 2009, 73(4):302-306.
51. Hotta O., Yusa N., Ooyama M., Unno K., Furuta T., Taguma Y. Detection of urinary macrophages expressing the CD16 (Fcgamma RIII) molecule: a novel marker of acute inflammatory glomerular injury. Kidney Int 1999, 55:1927-1934.